UroGen Pharma, a privately-held, clinical-stage biotechnology company, announced today that it has completed an agreement to license worldwide rights ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE